The case for & against
Bull & Bear analysis
Bearish
Eastman Kodak Company (NYSE: KODK) is a legacy technology company focused on imaging and printing solutions, including print, advanced materials, chemicals, and pharmaceuticals. Kodak has undergone substantial transformation in recent years, aiming to stabilize its core operations while investing in innovation and expanding into emerging sectors. The company is attempting to balance its traditional film business with new growth areas, particularly in commercial printing and advanced materials.
Bull says
- ↑Q1 revenue rose 7% YoY to $265M, operational EBITDA surged to $15M.
- ↑Advanced Materials & Chemicals division revenue grew 15% YoY, boosting margins.
- ↑Cash balance of $299M and $600M pension termination poised to cut debt.
- ↑New CGMP pharmaceutical facility FDA-registered, enabling regulated-mfg expansion.
- ↑High institutional ownership and strong liquidity support stock demand.
- ↑Analogue film resurgence in motion pictures offers unpriced upside potential.
Bear says
- ↓Net loss widened to $16M in Q1, erasing prior-year improvements.
- ↓Unfavorable valuation factors persist; earnings yield remains negative.
- ↓High leverage risk could strain cash flow if earnings don’t improve.
- ↓Stock volatility elevated, deterring risk-averse investors.
- ↓Digital shift threatens film segment, risking revenue stability.
- ↓Pharma expansion faces regulatory hurdles and potential approval delays.
Investment themes with KODK
Short Squeeze↓ -0.30%
Stocks prone to rapid price spikes from shorts
RGTI · QBTS · KODK
Earnings Call · Q1 2026 · Mgmt. Guidance
Updated 05-11-2026neutral
Transcript signals
Read full transcript analysis ›